Free Trial
NYSE:KVUE

Kenvue (KVUE) Stock Price, News & Analysis

$18.24
+0.29 (+1.62%)
(As of 07/2/2024 ET)
Today's Range
$17.99
$18.26
50-Day Range
$17.95
$20.63
52-Week Range
$17.75
$26.60
Volume
14.78 million shs
Average Volume
19.58 million shs
Market Capitalization
$34.93 billion
P/E Ratio
23.38
Dividend Yield
4.39%
Price Target
$23.09

Kenvue MarketRank™ Stock Analysis

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
26.6% Upside
$23.09 Price Target
Short Interest
Healthy
1.47% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.68mentions of Kenvue in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.69%
From $1.17 to $1.26 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.97 out of 5 stars

Consumer Staples Sector

44th out of 129 stocks

Toilet Preparations Industry

6th out of 13 stocks

KVUE stock logo

About Kenvue Stock (NYSE:KVUE)

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

KVUE Stock Price History

KVUE Stock News Headlines

URGENT: Another Country Abandons the Dollar
Vietnam just ditched the US dollar. And they're not alone. BRICS nations are rapidly moving away from the greenback, threatening the stability of your retirement savings. Your wealth could vanish overnight.
3 Healthcare Stocks to Buy Now: June 2024
The 7 Best Under $20 Stocks to Buy in June 2024
URGENT: Another Country Abandons the Dollar
Vietnam just ditched the US dollar. And they're not alone. BRICS nations are rapidly moving away from the greenback, threatening the stability of your retirement savings. Your wealth could vanish overnight.
Kenvue: A 4% Yield Worth Going Long
3 Dividend Aristocrats to Buy Today
Deep Dive Into Kenvue Stock: Analyst Perspectives (5 Ratings)
3 Healthcare Stocks to Buy Now: May 2024
Kenvue Announces Pricing of Secondary Offering
Kenvue Launches Secondary Offering Of 182.33 Mln Shares
Kenvue Announces Launch of Secondary Offering
See More Headlines
Receive KVUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Ex-Dividend for 5/22 Dividend
5/07/2024
Dividend Payable
5/22/2024
Today
7/02/2024
Next Earnings (Estimated)
7/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
N/A
Fax
N/A
Employees
22,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.09
High Stock Price Target
$28.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+26.6%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
14 Analysts

Profitability

Net Income
$1.66 billion
Pretax Margin
12.97%

Debt

Sales & Book Value

Annual Sales
$15.44 billion
Cash Flow
$1.58 per share
Book Value
$5.85 per share

Miscellaneous

Outstanding Shares
1,914,810,000
Free Float
1,911,560,000
Market Cap
$34.93 billion
Optionable
Optionable
Beta
1.41
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Thibaut Mongon (Age 53)
    CEO & Director
    Comp: $4.79M
  • Mr. Paul Ruh (Age 56)
    Chief Financial Officer
    Comp: $2.33M
  • Ms. Meredith Stevens (Age 61)
    Chief Operations Officer
    Comp: $1.84M
  • Mr. Carlton Lawson (Age 55)
    Group President of EMEA & Latin America
    Comp: $2.28M
  • Ms. Ellie Bing Xie (Age 54)
    Group President of Asia Pacific
    Comp: $2.94M
  • Ms. Heather R. Howlett (Age 46)
    Chief Accounting Officer
  • Mr. Bernardo Tavares (Age 56)
    Chief Data & Technology Officer
  • Dr. Caroline Tillett (Age 52)
    Chief Scientific Officer
  • Ms. Tina Romani
    Head of Investor Relations
  • Mr. Matthew Orlando (Age 47)
    General Counsel

Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Kenvue Inc.:

  • Kenvue Inc. reported a quarterly EPS of $0.28, exceeding analysts' consensus estimates by $0.03, indicating strong financial performance.
  • The company declared a quarterly dividend of $0.20 per share, offering investors a dividend yield of 4.34%, providing a steady income stream.
  • Several analysts have assigned a buy rating to Kenvue stock, suggesting positive sentiment and growth potential in the market.
  • Institutional investors and hedge funds own a significant portion (97.64%) of Kenvue's stock, indicating confidence from large financial entities.
  • Kenvue's current stock price is $18.52, potentially presenting a buying opportunity for investors looking for undervalued stocks.

Cons

Investors should be bearish about investing in Kenvue Inc. for these reasons:

  • Kenvue's quarterly revenue was down 24.9% on a year-over-year basis, indicating a decline in top-line growth.
  • The company's payout ratio is currently 102.56%, suggesting that it is paying out more in dividends than it is earning, which could be unsustainable in the long term.
  • One analyst has rated the stock with a sell rating, signaling potential concerns about the company's future performance.
  • Kenvue's debt-to-equity ratio of 0.66 may indicate higher financial leverage, which could pose risks during economic downturns.
  • The average target price for Kenvue stock is $23.09, which is higher than the current stock price, potentially indicating limited upside for investors.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, June 30, 2024. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

KVUE Stock Analysis - Frequently Asked Questions

Should I buy or sell Kenvue stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.
View KVUE analyst ratings
or view top-rated stocks.

What is Kenvue's stock price target for 2024?

14 equities research analysts have issued twelve-month price objectives for Kenvue's shares. Their KVUE share price targets range from $18.00 to $28.00. On average, they expect the company's share price to reach $23.09 in the next twelve months. This suggests a possible upside of 26.6% from the stock's current price.
View analysts price targets for KVUE
or view top-rated stocks among Wall Street analysts.

How have KVUE shares performed in 2024?

Kenvue's stock was trading at $21.53 at the beginning of the year. Since then, KVUE shares have decreased by 15.3% and is now trading at $18.24.
View the best growth stocks for 2024 here
.

Are investors shorting Kenvue?

Kenvue saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 29,700,000 shares, a decrease of 20.4% from the May 15th total of 37,300,000 shares. Based on an average daily volume of 20,370,000 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.6% of the company's stock are short sold.
View Kenvue's Short Interest
.

When is Kenvue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 18th 2024.
View our KVUE earnings forecast
.

How were Kenvue's earnings last quarter?

Kenvue Inc. (NYSE:KVUE) issued its earnings results on Tuesday, May, 7th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.03. The company earned $2.89 billion during the quarter, compared to analyst estimates of $3.79 billion. Kenvue had a trailing twelve-month return on equity of 21.06% and a net margin of 9.63%. The business's quarterly revenue was down 24.9% on a year-over-year basis.

How often does Kenvue pay dividends? What is the dividend yield for Kenvue?

Kenvue announced a quarterly dividend on Thursday, April 25th. Investors of record on Wednesday, May 8th will be paid a dividend of $0.20 per share on Wednesday, May 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.39%. The ex-dividend date is Tuesday, May 7th.
Read our dividend analysis for KVUE
.

Is Kenvue a good dividend stock?

Kenvue (NYSE:KVUE) pays an annual dividend of $0.80 per share and currently has a dividend yield of 4.40%. KVUE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 102.56%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, KVUE will have a dividend payout ratio of 63.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for KVUE.

What guidance has Kenvue issued on next quarter's earnings?

Kenvue issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of 1.100-1.200 for the period, compared to the consensus EPS estimate of 1.140. The company issued revenue guidance of $15.6 billion-$15.9 billion, compared to the consensus revenue estimate of $15.6 billion.

When did Kenvue IPO?

Kenvue (KVUE) raised $3.3 billion in an initial public offering on Thursday, May 4th 2023. The company issued 151,200,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank acted as the underwriters for the IPO.

Who are Kenvue's major shareholders?

Kenvue's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Modus Advisors LLC (0.01%), Transcend Capital Advisors LLC (0.00%), Davis Capital Management (0.00%), First Hawaiian Bank (0.00%), Park Place Capital Corp (0.00%) and GAMMA Investing LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of Kenvue?

Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:KVUE) was last updated on 7/3/2024 by MarketBeat.com Staff

From Our Partners